Tilray | TRLY - Trade Creditors

Stock Price
9.27
Daily Change
-0.28 -2.93%
Monthly
-14.17%
Yearly
918.68%
Q1 Forecast
9.24

Tilray reported $107.35M in Trade Creditors for its fiscal quarter ending in March of 2025.





Trade Creditors Change Date
Acasti Pharma USD 459K 881K Sep/2025
Akebia Therapeutics USD 21.18M 11.1M Dec/2025
Alaunos Therapeutics USD 843K 34K Sep/2025
Aurora Cannabis CAD 49.34M 31.94M Sep/2025
Avita Medical AUD 8.96M 1.69M Dec/2025
Canopy Growth CAD 18.14M 5.94M Sep/2025
Cronos Group USD 11.64M 775K Dec/2025
Dianthus Therapeutics USD 9.72M 3.02M Dec/2025
Divis Laboratories Ltd INR 10.4B 1.3B Sep/2025
Ionis Pharmaceuticals USD 14.33M 8.47M Sep/2025
IQVIA Holdings USD 3.75B 201M Dec/2025
Knight Therapeutics CAD 118.13M 8.16M Sep/2025
Moderna USD 317M 50M Dec/2025
Organigram Holdings CAD 89.25M 556K Sep/2025
Organon & Co USD 1.07B 7M Sep/2025
Revvity USD 185.46M 9.66M Dec/2025
Tectonic Therapeutic USD 1.09M 392K Dec/2025
Tilray USD 107.35M 8.43M Mar/2025
Viatris USD 1.33B 6.4M Sep/2025
Xeris Pharmaceuticals USD 3.08M 3.45M Dec/2025